phenyl acetate has been researched along with Familial Combined Hyperlipidemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AS; Davidson, MH; Davignon, J; Dujovne, CA; Heinonen, T; Insull, W; Keilson, LM; Koren, M; McLain, R; Schrott, H; Sprecher, D | 1 |
1 trial(s) available for phenyl acetate and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
Topics: Acetamides; Acetates; Adult; Aged; Double-Blind Method; Female; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Treatment Outcome | 2001 |